Search

everythinglearnresearchcommunity

for

Search:↓

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

M30 is a promising treatment for preventing hair loss during chemotherapy.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

A new method effectively predicts estrogen-related health effects for early screening.

Drug repurposing offers a faster, cheaper way to find treatments for rare diseases.

The document's conclusion cannot be provided because the document is not readable.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Three new gene mutations cause rickets and hair loss, treatable with high calcium and calcidol, but hair regrowth is rare.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Ion sequential therapy improves heart function after a heart attack.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.